What is OrbitalRX?
OrbitalRX is a technology firm dedicated to empowering pharmacy leaders through advanced drug supply management solutions. Their platform is designed to dismantle data silos, consolidating all pharmacy data into a unified, user-friendly interface. This aggregation of information is crucial for proactively managing drug shortages, saving valuable time for healthcare professionals and mitigating the persistent challenges posed by medication supply chain disruptions. The company's focus on operational efficiency and supply chain resilience makes it a key player in addressing critical healthcare logistics.
How much funding has OrbitalRX raised?
OrbitalRX has raised a total of $1.2M across 1 funding round:
Private Equity
$1.2M
Private Equity (2025): $1.2M, investors not publicly disclosed
What's next for OrbitalRX?
With a major enterprise-level funding round and a recent strategic investment, OrbitalRX is poised for significant scaling and innovation. The capital infusion is expected to fuel further development of their drug shortage management platform, potentially expanding its capabilities to include predictive analytics and enhanced supply chain visibility. This strategic backing suggests a focus on solidifying market leadership and potentially exploring new verticals within healthcare technology. The company's trajectory indicates a move towards broader enterprise adoption and deeper integration into critical healthcare infrastructure.
See full OrbitalRX company page
